CEP
ANIP icon

Chicago Equity Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Chicago Equity Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-21,418
Closed -$1.32M – 664
2019
Q4 		$1.32M Sell
21,418
-18,250
-46% -$1.21M 0.08% 381
2019
Q3 		$2.89M Sell
39,668
-7,800
-16% -$584K 0.14% 221
2019
Q2 		$3.9M Sell
47,468
-300
-0.6% -$21.3K 0.17% 154
2019
Q1 		$3.37M Buy
47,768
+615
+1% +$36.2K 0.13% 221
2018
Q4 		$2.12M Buy
47,153
+7,595
+19% +$398K 0.09% 326
2018
Q3 		$2.24M Buy
39,558
+1,483
+4% +$90.8K 0.07% 354
2018
Q2 		$2.54M Buy
38,075
+19,355
+103% +$1.21M 0.08% 339
2018
Q1 		$1.09M Sell
18,720
-3,850
-17% -$244K 0.03% 486
2017
Q4 		$1.46M Hold
22,570
– – 0.04% 429
2017
Q3 		$1.19M Buy
22,570
+2,745
+14% +$131K 0.04% 481
2017
Q2 		$928K Buy
19,825
+2,465
+14% +$119K 0.03% 517
2017
Q1 		$859K Buy
17,360
+860
+5% +$48.3K 0.02% 486
2016
Q4 		$1M Buy
16,500
+4,300
+35% +$263K 0.03% 462
2016
Q3 		$809K Buy
+12,200
New +$763K 0.02% 467

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Chicago Equity Partners's ANIP Position: Q1 2020 in Review

Chicago Equity Partners sold out of ANI Pharmaceuticals (ANIP) in Q1 2020, closing a stake of 21,418 shares — an estimated $1.32M sold.

Chicago Equity Partners first reported a position in ANIP in Q3 2016 and held it in 14 quarters. The position peaked at $3.9M in Q2 2019. 140 funds tracked by Wall St. Rank hold ANIP as of Q1 2020.

  • Chicago Equity Partners reported no remaining ANI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 21,418 ANI Pharmaceuticals shares in Q1 2020, an estimated $1.32M.
  • Chicago Equity Partners first reported a position in ANI Pharmaceuticals in Q3 2016 and held it in 14 quarters.
  • Chicago Equity Partners's ANI Pharmaceuticals position peaked at $3.9M in Q2 2019.
  • 140 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.